Dexamethasone Treatment after the First Week of Life for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review.

Article Description: 
Conclusions: The benefits of late dexamethasone may not outweigh actual or potential adverse effects. Given the evidence of both benefits and harms of treatment, and the limitations of the evidence at present, it appears prudent to reserve the use of late dexamethasone to infants who cannot be weaned from mechanical ventilation, and to minimise the dose and duration of any course of treatment. PMID: 20453523 [PubMed - as supplied by publisher] (Source: Neonatology)
http://www.medworm.com/index.php?rid=3556508&cid=c_1_69_f&fid=36786&url=...